Letter: Alectinib combined with cobimetinib in ALK-rearranged lung cancer: A phase IB study. Naveed F, Khan S, Khan A, Arshad F, et al. Lung Cancer 2025;202:108489.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Naveed F, Khan S, Khan A, Arshad F, et al. Letter: Alectinib combined with cobimetinib in ALK-rearranged lung cancer: A phase IB study. Lung Cancer 2025;202:108489.
PMID: 40117844